Wesfarmers Ltd (ASX:WES)
Wesfarmers Ltd (ASX:WES) is a 100-year-old conglomerate which at various times has owned and operated some of Australia’s largest retail brands such as Kmart, Target and more. Today, its largest business is Bunnings Warehouse, the number-one DIY home improvement business.
Wesfarmers Ltd (ASX:WES) share price
Wesfarmers Ltd (ASX:WES) share price news
ASX 200 hits 3-week high – WPL, WES & TLS shares in focus
Surges from CSL Limited (ASX:CSL) and BHP Group Ltd (ASX:BHP) shares powered the S&P/ASX 200 (ASX:XJO) to a three-week high on Thursday
11 ASX shares out with BIG dividends today – WES, TLS, S32 & more
ASX shares have been out with big earnings reports today and some even bigger dividends. Here are 11 that caught my eye.
Wesfarmers (ASX:WES) share price sinks 6% on supply chain issues, dividend cut
The Wesfarmers Ltd (ASX:WES) share price is down 6% after the blue chip ASX share reported a mostly disappointing result.
Wesfarmers (ASX:WES) share price on watch after profit and dividend cut
The Wesfarmers Ltd (ASX: WES) share price will be on watch today after announcing a 14% fall in profit for the first half of FY22.
Watchlist Wednesday: Wesfarmers Ltd (ASX:WES)
Today’s Watchlist Wednesday looks at one of the most well-known yet misunderstood companies on the ASX, Wesfarmers Ltd (ASX: WES).
Is the Wesfarmers (ASX:WES) share price too cheap to ignore?
The Wesfarmers Ltd (ASX:WES) share price has fallen to around a six-month low. Is it now too cheap to ignore?
ASX 200 morning report – WES, B4P & PPS shares in focus
The S&P/ASX 200 (ASX:XJO) started the week on a solid footing as Wesfarmers (ASX:WES) and Beforepay (ASX:B4P) shares made headlines.
Wesfarmers (ASX:WES) share price up despite 13% profit decline
The Wesfarmers Ltd (ASX: WES) share price is moving higher today despite profit for the half reversing 13% due to mandated pandemic closures.
Australian Pharmaceutical (ASX:API) share price sinks as Woolworths withdraws $1.75 bid
Woolworths Group Ltd (ASX: WOW) today announced it has withdrawn its $1.75 per share offer for Australian Pharmaceutical Industries Ltd (ASX: API).